Comprehensive conservative care in end-stage kidney disease

被引:2
|
作者
Palat, Gayatri [1 ,5 ,6 ]
Shenoy, Srinivas Vinayak [2 ]
Shetty, Lakshmitha [3 ]
Vishnubhotla, Sivakumar [4 ]
机构
[1] MNJ Inst Oncol & Reg Canc Ctr, Hyderabad, Telangana, India
[2] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Nephrol, Manipal, Karnataka, India
[3] Manipal Acad Higher Educ, Manipal Coll Hlth Profess, Dept Renal Replacement Therapy & Dialysis Technol, Manipal, Karnataka, India
[4] SVIMS, Dept Nephrol, Tirupati, Andhra Pradesh, India
[5] MNJ Inst, Pain Relief & Palliat Care Soc, Hyderabad, Telangana, India
[6] MNJ Inst, INCTR Canada Palliat Access PAX Program India, Hyderabad, Telangana, India
关键词
Conservative care; end-stage kidney disease; palliative care; ELDERLY-PATIENTS; SUPPORTIVE CARE; PALLIATIVE CARE; SYMPTOM BURDEN; MANAGEMENT; DIALYSIS; SURVIVAL; ADULTS;
D O I
10.4103/ijpc.ijpc_63_21
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In patients with end-stage kidney disease (ESKD), when there maybe situations where dialysis does not offer benefits in terms of survival or health-related quality of life, dialysis should not be viewed as the default therapy. Such patients can be offered comprehensive conservative care as an alternative to dialysis. Conservative (nondialytic) management of ESKD includes careful attention to fluid balance, treatment of anemia, correction of acidosis and hyperkalemia, blood pressure, and calcium/phosphorus metabolism management and dietary modification. Individualized symptom management and supportive care are crucial to maximize the quality of life. We propose that model of comprehensive conservative care in ESKD should manage both diseases as well as provide supportive care. Facilitating implementation of comprehensive conservative care requires coordination between nephrology and palliative care at patient, professional, administrative, and social levels to maximize benefit with the motto to improve the overall quality of life.
引用
收藏
页码:11 / 13
页数:3
相关论文
共 50 条
  • [41] Advance care planning in patients with end-stage renal disease
    Davison, Sara N.
    PROGRESS IN PALLIATIVE CARE, 2009, 17 (04) : 170 - 178
  • [42] End-stage kidney disease in Fiji
    Krishnan, Amrish
    Chandra, Yogeshni
    Malani, Joji
    Jesudason, Shilpanjali
    Sen, Shaundeep
    Ritchie, Angus G.
    INTERNAL MEDICINE JOURNAL, 2019, 49 (04) : 461 - 466
  • [43] Cerebrovascular disease in end-stage kidney disease
    Tsuruya K.
    Fujisaki K.
    Renal Replacement Therapy, 2 (1)
  • [44] Familial aggregation of end-stage kidney disease in Brazil
    Madeira, EPQ
    Santos, OD
    Santos, SFF
    da Silva, LA
    Innocenzi, AM
    Santoro-Lopes, G
    NEPHRON, 2002, 91 (04): : 666 - 670
  • [45] Care for end-stage kidney disease in China: progress, challenges, and recommendations
    Chen, Tiange
    Sun, Xuefeng
    Tsuei, Sian
    Yang, Ruirui
    Yip, Winnie
    Fu, Hongqiao
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 54
  • [46] Age-Dependent Effects of Acute Kidney Injury on End-Stage Kidney Disease and Mortality in Patients with Moderate to Severe Chronic Kidney Disease
    Chou, Yu-Hsiang
    Lai, Tai-Shuan
    Lin, Yi-Chih
    Chiang, Wen-Chih
    Chu, Tzong-Shinn
    Lin, Shuei-Liong
    Chen, Yung-Ming
    NEPHRON, 2023, 147 (06) : 329 - 336
  • [47] The use of implicit persuasion in decision-making about treatment for end-stage kidney disease
    van Dulmen, Sandra
    Peereboom, Emma
    Schulze, Lotte
    Prantl, Karen
    Rookmaaker, Maarten
    van Jaarsveld, Brigit C.
    Abrahams, Alferso C.
    Roodbeen, Ruud
    PERITONEAL DIALYSIS INTERNATIONAL, 2022, 42 (04): : 377 - 386
  • [48] Environmental Impact of Care for End-stage Kidney Disease on the Earth and Humans
    Nagai, Kei
    Itsubo, Norihiro
    JMA JOURNAL, 2022, 5 (01): : 109 - 113
  • [49] Factors that influence the selection of conservative management for end-stage renal disease - a systematic review
    Sakthivel, Pavithra
    Mostafa, Alyaa
    Aiyegbusi, Olalekan Lee
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [50] What to do with foundation therapies for heart failure for patients with end-stage kidney disease on haemodialysis
    Adenwalla, Sherna F.
    Hull, Katherine L.
    Graham-Brown, Matthew P. M.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (04)